Erasme Hospital
Brussels, Brussel-hoofdstad, 1070, Belgium
NCT Number: NCT04089644
Intraoperative hypotension can impact patient outcome. Vasopressors are usually used to correct hypotension and ensure adequate organ perfusion.
The investigators have recently developed an automated system (closed-loop system) to titrate vasopressor agents in surgical and intensive care patients.
The purpose of this study is to compare two strategies to correct hypotension based on an individual definition of hypotension (therefore, the target MAP used to define hypotension will differ for each patient (individualized approach):
1. Control group = standard practice ( manually adjusted norepinephrine infusion to correct hypotension and keep MAP within 90% of patient's baseline MAP 2. Intervention group = closed-loop (automated) vasopressor administration system will deliver norepinephrine using feedback from standard operating room hemodynamic monitor (EV1000 Monitor-Flotrac, Edwards Lifesciences, IRVINE, USA) to correct hypotension and keep MAP within 90% of patient's baseline MAP
Looking for future studies?
Notify Me18 year–99 year
All sexes
Interventional
Not applicable
Brussels, Brussel-hoofdstad, 1070, Belgium
In order to prevent the known postoperative complications of intraoperative hypotension, vasopressor agents are occasionally used to ensure adequate perfusion. These vasopressors are usually administered as manually adjusted infusions, but this practice requires considerable time and attention.
To overcome this issue, the investigators have developed a closed-loop vasopressor (CLV) controller to potentially correct hypotension more efficiently. After completing extensive in-silico, in-vivo studies and a pilot human trial in a small cohort of 20 patients, the investigators aimed to conduct now a randomized control trial comparing manual vasopressor adjustment versus closed-loop vasopressor adjustment in high risk patients undergoing major abdominal surgeries in order to correct hypotension during surgery
The primary outcome will be the incidence of hypotension (defined as a reduction of > 10% from patient's MAP target, or a allowed tolerance of 10% reduction from patient's baseline MAP). This has been chosen based on the recent study of Emmanuel Futier and colleagues (Effect of Individualized vs Standard Blood Pressure Management Strategies on Postoperative Organ Dysfunction Among High-Risk Patients Undergoing Major Surgery: A Randomized Clinical Trial. JAMA. 2017 Oct 10;318(14):1346-1357), even if it was originally done with systolic blood pressure
Participants in both groups will receive standard patient care in that in no way will their anesthetic or surgical procedure will be altered as part of the study, with the exception of vasopressor administration.
Fluids will be standardized in both groups and will be given as a continuous baseline infusion of 3 ml/kg/h (balanced crystalloid solution) and additional fluid boluses (mini fluid challenges of 100 ml) as a goal directed fluid therapy strategy to maintain stroke volume variation < 13%. The only difference is the way norepinephrine is delivered to the patient (manual versus closed-loop assisted)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hypotension will be corrected by an automated system for vasopressor administration.
Fluids will be given using a goal directed strategy (EV1000 Monitor, Edwards Lifesciences, Irvine, CA, USA)
Vasopressor agents will be manually adjusted (standard practice).
Fluids will be given using a goal directed strategy (EV1000 Monitor, Edwards Lifesciences, Irvine, CA, USA)
Time frame: At postoperative day 1
Undertreatment. Percentage of time during surgery in hypotension. The MAP used to define hypotension will differ for each patient (individualized approach)
Time frame: during surgery
Percentage of time during surgery in hypotension using the population target usually admitted and used in clinical studies (MAP < 65 mmHg)
Time frame: during surgery
Percentage of time during surgery with a MAP +/- 10 mmHg of the chosen MAP target.
Time frame: during surgery
Amount of vasopressors received
Time frame: during surgery
Mean Uretral perfusion index during surgery using the novel IKORUS urinary catheter recently available on the market
Time frame: during surgery
Mean Uretral perfusion index during the first 15 minutes of the surgery
Time frame: during surgery
Mean Uretral perfusion index during the last 15 minutes of the surgery
Time frame: during surgery
Mean cardiac index during surgery
Time frame: during surgery
Mean Stroke volume index during surgery
Time frame: during surgery
Mean Stroke volume variation during surgery
Time frame: during surgery
Amount of fluid received during surgery
Time frame: during surgery
Net fluid balance during surgery
Erasme University Hospital
Other
Physician-Directed vs Computer-Assisted Norepinephrine Administration in Patients Undergoing Major Abdominal Surgery: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07627607
Cardiovascular Diseases, Hypotension
Kütahya, Turkey (Türkiye)
View Trial DetailsNCT06892665
Cardiovascular Diseases, Cesarean Section Complications
Cheras, Kuala Lumpur, Malaysia
View Trial DetailsNCT07328620
Acute Kidney Injury, Cardiovascular Diseases
Ankara, Yenimahalle, Turkey (Türkiye)
View Trial DetailsNCT07585201
Blood Loss, Surgical, Cardiovascular Diseases
Zagazig, Sharqia Province, Egypt
View Trial Details